Resource Library
/
A Novel LC-MS/MS Assay for Quantifying Dermatan Sulfate as a Cerebrospinal Fluid Biomarker for Mucopolysaccharidosis II Disease
poster
A Novel LC-MS/MS Assay for Quantifying Dermatan Sulfate as a Cerebrospinal Fluid Biomarker for Mucopolysaccharidosis II Disease
Accumulation of dermatan sulfate (DS) in tissue and body fluid leads to mucopolysaccharidosis II (MPS II) disorder. The study aims to develop an LC-MS/MS assay to measure DS in human cerebrospinal fluid (CSF) as a biomarker.
Resources to Consider
journal
Development and validation of LC-MS/MS methods for the quantification...
Guadecitabine (SGI-110), a dinucleotide of β‑decitabine and deoxyguanosine, is currentl...
journal
Development and validation of an LC-MS/MS method for the...
Fascin is an actin-bundling protein that has been linked to tumor cell migration, invasion...
poster
Overcoming Stability Issues in the Development of an LC-MS/MS Method...
In this study, we develop an LC-MS/MS assay for quantifying Azacitidine in Human Plasma an...
poster
Development and Validation of an Ultra Sensitive LC-MS/MS Method for...
Midazolam is a widely used central nervous system depressant. It is used for the treatment...
poster
Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III...
In this study, we developed and validated an LC-MS/MS method for the simultaneous determin...
poster
Validation of a Low-Volume Plasma LC-MS/MS Method Using a...
With the development of more sensitive instrumentation, there is a greater need for smalle...
webinar
Bioanalysis of Liposome Drugs by LC-MS/MS
This webinar presents the history, introduction, applications, and regulatory consideratio...
ebook
Sequencing Assays for Biomarker Discovery and Pharmacodynamics in...
In this eBook, we navigate the landscape of biomarker discovery through genomic profiling,...
poster
AAIC 2025: Comparison of Plasma pTau217 Assays on Different Platforms
Plasma pTau217 was recently discovered as a prominent blood-based biomarker in the early d...
